global view constructed of white lines

Blog

Immunotherapy
January 10, 2021

The Power of Immunotherapy

by Santosh Kesari

Our immune systems hold the power—the power, that is, to treat cancer. Composed of various types of cells, tissues, and organs, the immune system serves as more than the body’s main defense against foreign invaders such as bacteria and viruses. It also recognizes cancer cells...

PNI 2021
January 1, 2021

PNI Founders’ Message 2021

by Guest Author

Although our medical community continues to strain under the burden of COVID-19, there has been hope, determination and progress. Neurological diseases do not stop and neither have we at Pacific Neuroscience Institute.

Caregivers left behind
December 28, 2020

Supporting Family Members, Friends and Caregivers After Loss

by Santosh Kesari

This article was published on U.S News and World report, December 11, 2020 For loved ones left behind during the pandemic, suffering may endure for years. AS I WRITE THIS, COVID-19 has taken the lives of nearly 300,000 Americans. Each death leaves behind a circle of...

November Clinical Trials at PNI
December 2, 2020

Clinical Trials Round-Up: December 2020

by Mini Gill

New Studies Blue Earth Diagnostics FLC-219: (PDF): An Open-label, Single-arm, Single-dose, Prospective, Multicenter Phase 2b Study to Establish Image Interpretation Criteria for 18F-Fluciclovine Positron Emission Tomography (PET) in Detecting Recurrent Brain Metastases After Radiation Therapy (PURSUE) (NCT04410367) Actively Recruiting Studies Brain Cancer (Primary) – Glioma Aadi Bioscience (PDF): A...

November Clinical Trials at PNI
November 2, 2020

Clinical Trials Round-Up: November 2020

by Mini Gill

Actively Recruiting Studies Brain Cancer (Primary) – Glioma Aadi Bioscience (PDF): A Phase 2, Open-label Study of ABI-009 (nab-Rapamycin) in Bevacizumab-naïve Patients with Recurrent High-grade Glioma and in Patients with Newly Diagnosed Glioblastoma (NCT03463265) Orbus Therapeutics (PDF): A Randomized Phase 3 Open-Label Study To Evaluate the Efficacy and Safety of Eflornithine...

zbt donates to pacific brain health center
October 7, 2020

ZBT Fraternity at UCLA Donates to PNI’s Brain Cancer Program

by Guest Author

Jack Verschleiser, a 2017 UCLA graduate who now oversees the university’s ZBT fraternity organization, was struck that two current members had personal experience with cancer. David Phillips, who graduated in June of this year successfully battled Hodgkin’s lymphoma for six months of his junior year....

Clinical Trials Round Up October 2020 Cover
October 2, 2020

Clinical Trials Round-Up: October 2020

by Mini Gill

Actively Recruiting Studies Brain Cancer (Primary) – Glioma Aadi Bioscience (PDF): A Phase 2, Open-label Study of ABI-009 (nab-Rapamycin) in Bevacizumab-naïve Patients with Recurrent High-grade Glioma and in Patients with Newly Diagnosed Glioblastoma (NCT03463265) Orbus Therapeutics (PDF): A Randomized Phase 3 Open-Label Study To Evaluate the Efficacy and Safety of Eflornithine...

PNI Super Doctors 2021
September 10, 2020

PNI’s Super Doctors 2021!

by Caroline Mekhiel

Nineteen of PNI’s doctors have been recognized as Super Doctors in the 2021 announcement of this prestigious industry standard award. Of note, Daniel F. Kelly, MD, Founder and Director of PNI, and expert neurosurgeon became a Hall of Fame Super Doctor. With his selection to...

Clinical Trials August 2020 Cover
September 1, 2020

Clinical Trials Round-Up: September 2020

by Mini Gill

Actively Recruiting Studies Brain Cancer (Primary) – Glioma Aadi Bioscience ( PDF ): A Phase 2, Open-label Study of ABI-009 (nab-Rapamycin) in Bevacizumab-naïve Patients with Recurrent High-grade Glioma and in Patients with Newly Diagnosed Glioblastoma ( NCT03463265 ) Orbus Therapeutics ( PDF ): A Randomized Phase 3 Open-Label Study To Evaluate the Efficacy and Safety of Eflornithine...

Thin Neuro Episode 6 POdcast Cover
August 19, 2020

Meet Minimally Invasive Brain Surgery’s Pathfinder | Dr. Chester Griffiths

by Anthony Effinger

The Think Neuro podcast from Pacific Neuroscience Institute takes you into the clinic, operating room and laboratory with doctors and surgeons who are tackling the most challenging brain diseases and disorders. Host: Anthony Effinger Subscribe: Google Podcasts | Apple Podcasts | Spotify | Simplecast Watch: YouTube Episode 6: Show Notes When patients ask him...

Last updated: August 26th, 2020